{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
First approved in 1983
Source:
NADA131310
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
Altrenogest (INN, USAN, BAN) (brand name Regumate), also known as allyltrenbolone, is a steroidal progestin that is widely used in veterinary medicine to suppress estrus in animals. Altrenogest is an orally active progestin developed for use in the horse. Altrenogest has been chemically modified by addition of a hydroxyl group and 3 carbon chain placed on carbon 17 of the progestin. Research has demonstrated that Altrenogest has low anabolic activity and is 20 times less potent than testosterone or similar progestins when compared for effects on muscle growth in castrated rats
Status:
Possibly Marketed Outside US
Source:
REVERSE IT KIT
Source URL:
First approved in 1983
Source:
ANDA088228
Source URL:
Class (Stereo):
CHEMICAL (MIXED)
Conditions:
GLYCERYL RICINOLEATE is a monoester of glycerin and ricinoleic acid. In cosmetic formulations Glyceryl ricinoleate can have the following functions: emulsifier/co-emulsifier, refatting agent, dispersing aid. But the primary function of Glyceryl ricinoleate is a skin protection agent. Glyceryl ricinoleate is used in nearly all skin care preparations such as creams, lotions, bath oils, shaving formulations, refatting soap and shower agents in amounts of 2 – 10%. In an epicutaneous test and after long use in cosmetic preparations, no irritations were observed.
Status:
US Approved Rx
(1997)
Source:
ANDA074900
(1997)
Source URL:
First approved in 1983
Source:
TRACRIUM PRESERVATIVE FREE by HOSPIRA
Source URL:
Class:
MIXTURE
Conditions:
Atracurium is an intermediate-duration, nondepolarizing, skeletal muscle relaxant for intravenous administration. It is used, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Most adverse reactions were suggestive of histamine release. Common side effects include flushing of the skin and low blood pressure. Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine.
Status:
US Approved OTC
Source:
21 CFR 346.14(a)(4) anorectal:protectant hard fat
Source URL:
First approved in 1983
Source:
ANDA086557
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 334
(2010)
Source URL:
First approved in 1983
Source:
NDA018723
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
First approved in 1983
Source:
NDA019555
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333
(2010)
Source URL:
First approved in 1983
Source:
NDA019555
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NCT04026438: Phase 4 Interventional Completed Complication, Postoperative
(2019)
Source URL:
First approved in 1983
Source:
NADA125961
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NDA018642
(1983)
Source URL:
First approved in 1983
Source:
NDA018642
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
FLUIDBASE AHA 10 by LABORATORIO GENOVE S.A.
(2016)
Source URL:
First approved in 1983
Source:
NDA018861
Source URL:
Class:
POLYMER
